Revolutionize Your Xarelto Lawsuit With These Easy-peasy Tips

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are operating challenging to get those hurt by the drug the compensation they are entitled to. Although bleeding is really a common complication related with anticoagulants, it has been alleged that Xarelto is much more unsafe than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, patients might be at risk for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging. Should you or possibly a loved one suffered a significant bleeding event soon after taking Xarelto, you might have legal recourse. For much more details, contact us today to have your case reviewed, free of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral costs. Additionally, they may be seeking punitive damages, that are normally awarded to punish the defendant and deter other companies from acting similarly. Why Are Lawsuits Becoming Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a secure anticoagulant option. Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion. Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting. Visit this page for much more details on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys within the Complex Litigation Group have  similar resource site filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.